What is he best known for?
The fields of study he is best known for:
- Cancer
- Gene
- Internal medicine
His primary areas of study are Multiple myeloma, Cancer research, Bortezomib, Bone marrow and Immunology.
He is interested in Thalidomide, which is a field of Multiple myeloma.
The Cancer research study combines topics in areas such as Cell cycle, Cytokine, Bone disease and Cell growth.
His Bortezomib research integrates issues from Proteasome inhibitor, Apoptosis, Growth inhibition, Lenalidomide and In vivo.
His Bone marrow research is multidisciplinary, incorporating elements of Cell culture, Peripheral blood mononuclear cell and Cell killing.
His Internal medicine study integrates concerns from other disciplines, such as Gastroenterology, Endocrinology, Surgery and Oncology.
His most cited work include:
- Vemurafenib in Multiple Nonmelanoma Cancers with BRAF V600 Mutations (972 citations)
- Thalidomide and its analogs overcome drug resistance of human multiple myeloma cells to conventional therapy. (853 citations)
- Thalidomide and its analogs overcome drug resistance of human multiple myeloma cells to conventional therapy. (853 citations)
What are the main themes of his work throughout his whole career to date?
His primary areas of investigation include Multiple myeloma, Internal medicine, Cancer research, Oncology and Bortezomib.
His Multiple myeloma study combines topics in areas such as Bone disease, Bone marrow, Dexamethasone and Pharmacology.
Noopur Raje has included themes like Gastroenterology, Endocrinology and Surgery in his Internal medicine study.
His studies deal with areas such as Cell culture, Cell growth, Apoptosis, Immunology and Kinase as well as Cancer research.
His Cell culture research is multidisciplinary, relying on both Molecular biology and Cytotoxicity.
His studies deal with areas such as Proteasome inhibitor and Refractory as well as Bortezomib.
He most often published in these fields:
- Multiple myeloma (54.06%)
- Internal medicine (40.59%)
- Cancer research (33.16%)
What were the highlights of his more recent work (between 2016-2021)?
- Multiple myeloma (54.06%)
- Internal medicine (40.59%)
- Oncology (22.28%)
In recent papers he was focusing on the following fields of study:
Noopur Raje mostly deals with Multiple myeloma, Internal medicine, Oncology, Cancer research and In patient.
His Multiple myeloma research incorporates themes from Denosumab and Dexamethasone.
His biological study deals with issues like Gastroenterology, which deal with fields such as Neutropenia.
As part of the same scientific family, he usually focuses on Oncology, concentrating on Cohort and intersecting with Histology and Clinical endpoint.
In his study, Chimeric antigen receptor is inextricably linked to Antigen, which falls within the broad field of Cancer research.
The study incorporates disciplines such as Regimen, Adverse effect and Transplantation in addition to Lenalidomide.
Between 2016 and 2021, his most popular works were:
- Anti-BCMA CAR T-Cell Therapy bb2121 in Relapsed or Refractory Multiple Myeloma (422 citations)
- Daratumumab plus Lenalidomide and Dexamethasone for Untreated Myeloma. (282 citations)
- Multiple Myeloma, Version 3.2017, NCCN Clinical Practice Guidelines in Oncology (184 citations)
In his most recent research, the most cited papers focused on:
- Cancer
- Gene
- Internal medicine
Noopur Raje mainly focuses on Multiple myeloma, Internal medicine, Oncology, Cancer research and Chimeric antigen receptor.
Noopur Raje has included themes like MEDLINE, T cell, Tolerability, Dexamethasone and Bone disease in his Multiple myeloma study.
His study explores the link between Dexamethasone and topics such as Bortezomib that cross with problems in Pharmacology and Proteasome inhibitor.
His research in Internal medicine focuses on subjects like Gastroenterology, which are connected to Waldenstrom macroglobulinemia and Leukemia.
Noopur Raje has researched Oncology in several fields, including Plasma cell, Chemotherapy and Daratumumab.
His research in Cancer research is mostly concerned with Glioma.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
